Assignment of Assignor's Interest

Recorded: 2008-06-23 Pages: 4

Assignor

DAMBINOVA, SVETLANA, DR.

Executed: 2008-06-09

Assignee

CIS BIOTECH, INC.

1755 LOGANS KNOLL, ATLANTA, GEORGIA, 30329

Covered Properties (10)

Ischemic Biomarkers and Their Use to Predict Adverse Neurological Events from Sugery

PCT: PCT/US2006/002306 ↗

Methods for Diagnosing and Treating Cerebrovascular Events Based on NR2 Peptides

PCT: PCT/US2006/023020 ↗

Nmdar Biomarkers for Diagnosing and Treating Cerebral Ischemia

PCT: PCT/US2007/087278 ↗

Ischemic biomarkers and their use to predict adverse neurological events from surgery

Application: 11/338,447 →

Publication: US 2006/0257943

Methods for diagnosing and treating cerebrovascular events based on NR2 peptides

Application: 11/451,679 →

Publication: US 2006/0281135

Ischemic Biomarkers and their Use to Predict Adverse Neurological Events from Surgery

Application: 11/814,379 →

Publication: US 2008/0206793

Methods for Diagnosing Cerebrovascular Events Based on NR2 Peptides

Patent: 8,084,225 →

Application: 11/916,507 →

Publication: US 2009/0181006

Rapid blood tests for risk assessment of neurological adverse events before surgery

Application: 60/646,762 →

NR2 peptide for diagnosis/prognosis of cerebrovascular events

Application: 60/689,806 →

NMDAR biomarkers for diagnosing and treating cerebral ischemia

Application: 60/874,356 →

Related Assignments (2)

Other recorded transfers of the patents in this record — the chain of ownership.